Previous 10 | Next 10 |
2024-03-17 10:45:34 ET 3 Tips for Capitalizing on Market Cycles to Make Money With Penny Stocks Capitalizing on market cycles offers a strategic advantage in trading penny stocks, enabling investors to navigate through volatility and harness opportunities for significant returns. Unders...
2024-03-17 08:31:29 ET Friday saw an unprecedented surge in the stock of Geron Corporation (NASDAQ:GERN), with shares ending the day up a staggering 92%. This surge, marking a historic milestone for the company, was ignited by a momentous announcement earlier in the day. An FDA advi...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...
2024-03-15 12:52:05 ET More on Mid-day movers & stocks. Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Solidion Technology climbs 10% on $3.85M private placement Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M beats by $0.4M Financial i...
2024-03-15 12:42:01 ET DENVER, Colo., Mar 15, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Verb Technology (NASDAQ: VERB ), Geron Corporation (NASDAQ: GERN ), Brera Holding ( NASDAQ:BREA ), Prairie Operating Co. (NASDAQ:PROP), a...
Geron Corporation (NASDAQ: GERN) is one today's most active stocks by volume. So far today, approximately 40.37M shares of Geron Corporation have been exchanged, as compared to an average 30-day volume of 11.93M shares. Geron Corporation, a late-stage clinical biopharmaceutical company, focuse...
2024-03-15 10:06:29 ET More on Geron Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron wins FDA...
2024-03-15 10:00:13 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston...
A look at the top 10 most actives in the United States Grab Holdings Limited (GRAB) fell 0.2% to $3.235 on volume of 103,635,000 shares Better Therapeutics Inc. (BTTX) rose 108.6% to $0.073 on volume of 98,804,254 shares Verb Technology Company Inc. (VERB) rose 156.3% to $0.3639 on volume...
2024-03-15 09:34:33 ET DENVER, Colo., Mar 15, 2024 ( 247marketnews.com )- Geron Corporation (NASDAQ: GERN ) announced that the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 12 to 2 in favor of the clinical benefit/risk profile of imetelstat, based on results from the ...
News, Short Squeeze, Breakout and More Instantly...
RYTELO, for both RS+ and RS- patients, has a Category 1 recommendation for second-line treatment and a Category 2A recommendation for first-line treatment of patients who are ESA ineligible (serum EPO >500 mU/mL) Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice President, Corporate Strategy and Chief Commercial Officer, will depart the Company on August 31, 2024, to ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its second quarter 2024 financial results and business highlights before the market opens on Thursday, August 8, 2024 via press release, which will be available on the Company ...